NCT02479178 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02479178
Title	A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)
Acronym	iNSITE2
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	BIND Therapeutics
Indications	cervical cancer urethra transitional cell carcinoma bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma cholangiocarcinoma head and neck squamous cell carcinoma bile duct carcinoma
Therapies	BIND-014
Age Groups:	adult
Covered Countries	USA

NCT02479178
Clinical Trial Detail